Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Predictive test for melanoma patient benefit from interleukin-2 (IL2) therapy

Predictive test for melanoma patient benefit from interleukin-2 (IL2) therapy

US Patent 11710539 · Granted Jul 25, 2023

Estimated economic value: $2,225,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Predictive test for patient benefit from antibody drug blocking ligand activatio2025
Predictive test for patient benefit from antibody drug blocking ligand activatio2025
Predictive test for patient benefit from antibody drug blocking ligand activatio2025
Predictive test for patient benefit from antibody drug blocking ligand activatio2025
Apparatus and method for identification of primary immune resistance in cancer p2024
Apparatus and method for identification of primary immune resistance in cancer p2024
Apparatus and method for identification of primary immune resistance in cancer p2024
Methods and systems for automatic call data generation2024
Calibrated risk scoring and sampling2024
Using a traffic monitoring service to detect traffic pattern shifts2024
Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitaliz2024
Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitaliz2024